Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Apr 1 2018

Sites of Action for Cardiac Drugs

Images
https://upload.medbullets.com/topic/108074/images/cardiacdrugssitesofaction.jpg
https://upload.medbullets.com/topic/108074/images/dig mechanism.jpg
  • Snapshot
    • A 24-year-old woman presents with tachycardia. She reports that this happens every few years without any identifiable causes. Her pulse is 200/min. Her other vital signs are stable. An electrocardiogram shows a patient with narrow complex QRS, tachycardia to 204/min, and a regular rhythm. She is given a medication to slow down the atrioventricular node and attempt to end the narrow complex tachycardia. (Adenosine)
  • Introduction
    • Adenosine
      • mechanism of action
        • ↑ K+ out of the cells, which hyperpolarizes the cell and causes ↓ AV nodal conduction
    • Calcium channel blockers
      • mechanism of action
        • directly blocks L-type voltage-gated Ca2+ channels (dihydropyridine receptors)
      • background
        • action potential causes a rush of Ca2+ into the cell
        • Ca2+ enters via L-type voltage-gated Ca2+ channels
    • β-blockers
      • mechanism of action
        • indirectly blocks L-type voltage-gated Ca2+ channels (dihydropyridine receptors) via ↓ cAMP
      • background
        • positive inotropy by ↑ sympathetic nervous system is mediated by β1 receptors at the SA and AV nodes
flashcard locked
Create a free account or log in to see the cards.
Question
1 of 2
Cardiovascular | Sites of Action for Cardiac Drugs
  • Cardiovascular
  • - Sites of Action for Cardiac Drugs
6:26 min
8/7/2023
105 plays
4.0
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
(2)
Private Note